Rheumatology
News
Ilaris: FDA Asks if Gout Symptom Relief Is Worth Infection Risks
News
Canakinumab Shows Efficacy, Safety for Gouty Arthritis
Major Finding: At 3 days after a single drug dose, gouty arthritis patients who were treated with canakinumab had a statistically significant,...
News
Ankylosing Spondylitis: Recent Developments in Treatment
News
Socioeconomic Factors Linked to Complications of Giant Cell Arteritis
Conference Coverage
Rheumatoid Society Addresses Employment Disparity
News
Rituximab Deemed Useful for Certain Lupus Subgroups
News
Induction-Maintenance Treatment Succeeds in Early RA
Major Finding: A majority of patients with early RA who achieved a stable state of low disease activity after 26 weeks of treatment with...
News
Rilonacept Reduces Gout Flares Triggered by Urate-Lowering Therapy
Major Finding: The interleukin-1 inhibitor rilonacept reduced the rate of acute gout flares through 16 weeks of treatment by 54% in patients...
News
Unguided Intra-Articular Injections of Betamethasone Safe, Effective
News
Bosentan May Reduce Skin Fibrosis in Scleroderma
News
Black Osteoarthritis Patients Tend to Balk at Total Knee Replacement
Major Finding: The adjusted odds ratio for willingness to undergo TKR was 0.38 comparing black vs. white patients (95% CI, 0.19-0.74; P = .005)....